Enhanced expression of p210BCR/ABL and aberrant expression of Zfp423/ZNF423 induce blast crisis of chronic myelogenous leukemia.

Chronic myelogenous leukemia (CML) is a hematopoietic disorder originating from p210BCR/ABL-transformed stem cells, which begins as indolent chronic phase (CP) but progresses into fatal blast crisis (BC). To investigate molecular mechanism(s) underlying disease evolution, CML-exhibiting p210BCR/ABL transgenic mice were crossed with BXH2 mice that transmit a replication-competent retrovirus. Whereas nontransgenic mice in the BXH2 background exclusively developed acute myeloid leukemia, p210BCR/ABL transgenic littermates developed nonmyeloid leukemias, in which inverse polymerase chain reaction detected 2 common viral integration sites (CISs). Interestingly, one CIS was transgene's own promoter, which up-regulated p210BCR/ABL expression. The other was the 5' noncoding region of a transcription factor, Zfp423, which induced aberrant Zfp423 expression. The cooperative activities of Zfp423 and p210BCR/ABL were demonstrated as follows: (1) introduction of Zfp423 in p210BCR/ABL transgenic bone marrow (BM) cells increased colony-forming ability, (2) suppression of ZNF423 (human homologue of Zfp423) in ZNF423-expressing, p210BCR/ABL-positive hematopoietic cells retarded cell growth, (3) mice that received a transplant of BM cells transduced with Zfp423 and p210BCR/ABL developed acute leukemia, and (4) expression of ZNF423 was found in human BCR/ABL-positive cell lines and CML BC samples. These results demonstrate that enhanced expression of p210BCR/ABL and deregulated expression of Zfp423/ZNF423 contribute to CML BC.

[1]  Yoshiaki Ito,et al.  Haploinsufficiency of Runx1/AML1 promotes myeloid features and leukaemogenesis in BXH2 mice , 2005, British journal of haematology.

[2]  K. Akashi,et al.  Inducible expression of BCR/ABL using human CD34 regulatory elements results in a megakaryocytic myeloproliferative syndrome. , 2003, Blood.

[3]  D. Malo,et al.  A mutation in the Icsbp1 gene causes susceptibility to infection and a chronic myeloid leukemia–like syndrome in BXH-2 mice , 2005, The Journal of experimental medicine.

[4]  J. Massagué,et al.  OAZ Uses Distinct DNA- and Protein-Binding Zinc Fingers in Separate BMP-Smad and Olf Signaling Pathways , 2000, Cell.

[5]  Satoru Takahashi,et al.  Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice , 2005, Oncogene.

[6]  Kathryn E. Hentges,et al.  Evi3, a zinc-finger protein related to EBFAZ, regulates EBF activity in B-cell leukemia , 2005, Oncogene.

[7]  V. Kaartinen,et al.  BCR/ABL P210 and P190 cause distinct leukemia in transgenic mice. , 1995, Blood.

[8]  K. Tokunaga,et al.  FcgammaRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling. , 2005, Human molecular genetics.

[9]  X Zhang,et al.  Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: a novel model for chronic myelogenous leukemia. , 1998, Blood.

[10]  Trib1 and Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis. , 2007, Blood.

[11]  R. Y. Tsai,et al.  Cloning and Functional Characterization of Roaz, a Zinc Finger Protein that Interacts with O/E-1 to Regulate Gene Expression: Implications for Olfactory Neuronal Development , 1997, The Journal of Neuroscience.

[12]  H. Heimpel,et al.  Karyotype abnormalities and their clinical significance in blast crisis of chronic myeloid leukemia , 1997, Journal of Molecular Medicine.

[13]  J. Melo,et al.  The molecular biology of chronic myeloid leukemia. , 2000, Blood.

[14]  Jun Wu,et al.  An activating immunoreceptor complex formed by NKG2D and DAP10. , 1999, Science.

[15]  Y. Yazaki,et al.  Expression of p210bcr/abl by metallothionein promoter induced T-cell leukemia in transgenic mice. , 1995, Blood.

[16]  G. Sauvageau,et al.  Identification of cooperative genes for NUP98-HOXA9 in myeloid leukemogenesis using a mouse model. , 2005, Blood.

[17]  M. Grusby,et al.  Biology of IL‐21 and the IL‐21 receptor , 2004, Immunological reviews.

[18]  N. Copeland,et al.  Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis. , 2005, Blood.

[19]  T. Kawamoto,et al.  Identification of Functional Hypoxia Response Elements in the Promoter Region of the DEC1 and DEC2 Genes* , 2002, The Journal of Biological Chemistry.

[20]  J. Rowley.  A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining , 1973, Nature.

[21]  Michael J. Wilson,et al.  Cutting edge: KAP10, a novel transmembrane adapter protein genetically linked to DAP12 but with unique signaling properties. , 1999, Journal of immunology.

[22]  N. Copeland,et al.  Zfp423 Is Required for Normal Cerebellar Development , 2006, Molecular and Cellular Biology.

[23]  K. Tokunaga,et al.  FcγRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling , 2005 .

[24]  R. Ren,et al.  Mechanisms of BCR–ABL in the pathogenesis of chronic myelogenous leukaemia , 2005, Nature Reviews Cancer.

[25]  M. Ochi,et al.  Overexpression/enhanced kinase activity of BCR/ABL and altered expression of Notch1 induced acute leukemia in p210BCR/ABL transgenic mice , 2008, Oncogene.

[26]  Takeshi Suzuki,et al.  RTCGD: retroviral tagged cancer gene database , 2004, Nucleic Acids Res..

[27]  T. Kitamura,et al.  Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. , 2003, Experimental hematology.

[28]  W. Leonard,et al.  Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation , 2005, Nature Reviews Immunology.

[29]  M. Santoro,et al.  Cloning and molecular characterization of a novel gene strongly induced by the adenovirus E1A gene in rat thyroid cells , 2003, Oncogene.

[30]  N. Copeland,et al.  Evi3, a common retroviral integration site in murine B-cell lymphoma, encodes an EBFAZ-related Krüppel-like zinc finger protein. , 2003, Blood.

[31]  E. Canaani,et al.  Fused transcript of abl and bcr genes in chronic myelogenous leukaemia , 1985, Nature.

[32]  M. Rauchman,et al.  A Conserved 12-Amino Acid Motif in Sall1 Recruits the Nucleosome Remodeling and Deacetylase Corepressor Complex* , 2006, Journal of Biological Chemistry.

[33]  B. Calabretta,et al.  The biology of CML blast crisis. , 2004, Blood.

[34]  Y. Yazaki,et al.  Acquired loss of p53 induces blastic transformation in p210(bcr/abl)-expressing hematopoietic cells: a transgenic study for blast crisis of human CML. , 2000, Blood.

[35]  L. Bullinger,et al.  Early hematopoietic zinc finger protein-zinc finger protein 521: a candidate regulator of diverse immature cells. , 2008, The international journal of biochemistry & cell biology.

[36]  Jon C. Aster,et al.  Efficient and Rapid Induction of a Chronic Myelogenous Leukemia-Like Myeloproliferative Disease in Mice Receiving P210 bcr/abl-Transduced Bone Marrow , 1998 .

[37]  D. Tenen,et al.  Reversibility of acute B-cell leukaemia induced by BCR–ABL1 , 2000, Nature Genetics.

[38]  T. Kitamura,et al.  Plat-E: an efficient and stable system for transient packaging of retroviruses , 2000, Gene Therapy.

[39]  J. Shaughnessy,et al.  Leukaemia disease genes: large-scale cloning and pathway predictions , 1999, Nature Genetics.

[40]  Y. Yazaki,et al.  Development of acute lymphoblastic leukemia and myeloproliferative disorder in transgenic mice expressing p210bcr/abl: a novel transgenic model for human Ph1-positive leukemias. , 1998, Blood.

[41]  J. Stephenson,et al.  A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia , 1982, Nature.

[42]  Y. C. Chen,et al.  Chromosomal characteristics of Ph-positive chronic myelogenous leukemia in transformation. A study of 23 Chinese patients in Taiwan. , 1989, Cancer genetics and cytogenetics.

[43]  George Q. Daley,et al.  The P190, P210, and P230 Forms of the BCR/ABL Oncogene Induce a Similar Chronic Myeloid Leukemia–like Syndrome in Mice but Have Different Lymphoid Leukemogenic Activity , 1999, The Journal of experimental medicine.

[44]  Susan M. Watanabe,et al.  An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity , 1984, Cell.

[45]  A. Miyawaki,et al.  A new red fluorescent protein that allows efficient marking of murine hematopoietic stem cells , 2008, The journal of gene medicine.

[46]  B. Göttgens,et al.  Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis. , 2005, Blood.

[47]  T. Inaba,et al.  Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia. , 2003, Blood.

[48]  R. Y. Tsai,et al.  Identification of DNA Recognition Sequences and Protein Interaction Domains of the Multiple-Zn-Finger Protein Roaz , 1998, Molecular and Cellular Biology.

[49]  J. Stephenson,et al.  Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22 , 1984, Cell.

[50]  J. Inazawa,et al.  Identification of a novel fusion gene in a pre‐B acute lymphoblastic leukemia with t(1;19)(q23;p13) , 2004, Cancer science.

[51]  N. Copeland,et al.  Early B-cell factor-associated zinc-finger gene is a frequent target of retroviral integration in murine B-cell lymphomas , 2004, Oncogene.

[52]  F. Salvatore,et al.  BCR/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlations , 2002, Oncogene.

[53]  P. Pandolfi,et al.  Role of Dok-1 and Dok-2 in Leukemia Suppression , 2004, The Journal of experimental medicine.